Combining Hepatic Arterial Interventional Therapies with Lenvatinib and Programmed Cell Death-1 Inhibitors for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Single-Center, Real-World Study

Shen X, Shao T, Yu J, Zhang Z

Journal of Hepatocellular Carcinoma 2025, 12:1267-1278

Published Date: 2 July 2025